These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7096523)

  • 1. An automated HPLC assay for simultaneous quantitation of methylated xanthines and uric acids in urine.
    Tang-Liu DD; Riegelman S
    J Chromatogr Sci; 1982 Apr; 20(4):155-9. PubMed ID: 7096523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HPLC determination of five caffeine metabolites].
    Lu JF; Yi T; Cao XM; Zhuo HT; Lin SS
    Yao Xue Xue Bao; 1997 Aug; 32(8):607-11. PubMed ID: 11596311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of novel solid-phase extraction sorbent materials for high-performance liquid chromatography quantitation of caffeine metabolism products methylxanthines and methyluric acids in samples of biological origin.
    Georgia KA; Samanidou VF; Papadoyannis IN
    J Chromatogr B Biomed Sci Appl; 2001 Aug; 759(2):209-18. PubMed ID: 11499474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separation, pre-concentration, and HPLC analysis of methylxanthines in urine samples.
    Zydroń M; Baranowski J; Baranowska I
    J Sep Sci; 2004 Oct; 27(14):1166-72. PubMed ID: 15537072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human N-acetylation genotype determination with urinary caffeine metabolites.
    Kilbane AJ; Silbart LK; Manis M; Beitins IZ; Weber WW
    Clin Pharmacol Ther; 1990 Apr; 47(4):470-7. PubMed ID: 2328555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of the activity of cytochrome P-450 CYP2A6 by HPLC method with caffeine as metabolizing probe].
    Li J; Peng XQ; Zhang J; Xu JP
    Yao Xue Xue Bao; 2006 Mar; 41(3):282-4. PubMed ID: 16759004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo evaluation of CYP1A2, CYP2A6, NAT-2 and xanthine oxidase activities in a Greek population sample by the RP-HPLC monitoring of caffeine metabolic ratios.
    Begas E; Kouvaras E; Tsakalof A; Papakosta S; Asprodini EK
    Biomed Chromatogr; 2007 Feb; 21(2):190-200. PubMed ID: 17221922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of xanthine- and uric acid-related compounds in urine using a "dilute-and-shoot" technique coupling ultra-high-performance liquid chromatography and high-resolution Orbitrap mass spectrometry.
    Rodriguez A; Gomila RM; Martorell G; Costa-Bauza A; Grases F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Nov; 1067():53-60. PubMed ID: 28992566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary metabolites of caffeine in pregnant women.
    Scott NR; Chakraborty J; Marks V
    Br J Clin Pharmacol; 1986 Oct; 22(4):475-8. PubMed ID: 3768258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeine metabolism in the newborn.
    Aldridge A; Aranda JV; Neims AH
    Clin Pharmacol Ther; 1979 Apr; 25(4):447-53. PubMed ID: 428190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPLC method for rapid determination of acetylator phenotype by measuring urinary caffeine metabolites.
    Klebovich I; Arvela P; Pelkonen O
    J Pharm Biomed Anal; 1993 Oct; 11(10):1017-21. PubMed ID: 8305582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary excretion of caffeine and its metabolites in the mouse.
    Burg AW; Stein ME
    Biochem Pharmacol; 1972 Apr; 21(7):909-22. PubMed ID: 5039751
    [No Abstract]   [Full Text] [Related]  

  • 13. Determination of theophylline and its metabolites in human urine and serum by high-pressure liquid chromatography.
    Thompson RD; Nagasawa HT; Jenne JW
    J Lab Clin Med; 1974 Oct; 84(4):584-93. PubMed ID: 4412772
    [No Abstract]   [Full Text] [Related]  

  • 14. Urinary excretion of an uracilic metabolite from caffeine by rat, monkey and man.
    Latini R; Bonati M; Marzi E; Garattini S
    Toxicol Lett; 1981 Jan; 7(3):267-72. PubMed ID: 7222102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of caffeine metabolite for the evaluation of N-acetyltransferase, CYP1A2 and xanthine oxidase activities].
    Lu JF; Yi T; Cao XM; Zhuo HT; Ling SS
    Yao Xue Xue Bao; 1997 Nov; 32(11):813-8. PubMed ID: 11596199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the quantitative determination of xanthines and uric acids in urine.
    DIKSTEIN S; BERGMANN F; CHAIMOVITZ M
    J Biol Chem; 1958 Jan; 230(1):203-11. PubMed ID: 13502389
    [No Abstract]   [Full Text] [Related]  

  • 17. Simultaneous determinations by theophylline and its major metabolites in urine by reversed-phase ion-pair high-performance liquid chromatography.
    Muir KT; Jonkman JH; Tang DS; Kunitani M; Riegelman S
    J Chromatogr; 1980 Nov; 221(1):85-95. PubMed ID: 7451627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450 2A6 Phenotyping Using Dietary Caffeine Salivary Metabolite Ratios and Genotyping Using Blood on Storage Cards in Non-smoking Japanese Volunteers.
    Murayama N; Shimizu M; Kobayashi K; Kishimoto I; Yamazaki H
    Drug Metab Lett; 2017; 10(4):240-243. PubMed ID: 27842485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary biomarkers for assessing dietary exposure to caffeine.
    Crews HM; Olivier L; Wilson LA
    Food Addit Contam; 2001 Dec; 18(12):1075-87. PubMed ID: 11761118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotyping of N-acetyltransferase type 2 by caffeine from uncontrolled dietary exposure.
    Jetter A; Kinzig-Schippers M; Illauer M; Hermann R; Erb K; Borlak J; Wolf H; Smith G; Cascorbi I; Sörgel F; Fuhr U
    Eur J Clin Pharmacol; 2004 Mar; 60(1):17-21. PubMed ID: 14747882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.